• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Travel nightmare worsens as FAA cuts prompt thousands of flight disruptions

admin - Latest News - November 10, 2025
admin
16 views 26 secs 0 Comments



More than 8,000 flights have been delayed and 2,000 were canceled so far on Sunday evening after reductions went into effect Friday at 40 high-traffic airports, in what officials say is an attempt to relieve pressure amid the record-long government shutdown. NBC News’ Shaquille Brewster reports from Chicago O’Hare International Airport.



Source link

TAGS:
PREVIOUS
Senators reach tentative deal to end the government shutdown
NEXT
New deal emerges that could end government shutdown
Related Post
September 29, 2025
Sept. 29, 2025, 5:00 AM EDTBy Scott Wong, Sahil Kapur and Yamiche AlcindorWASHINGTON — President Donald Trump is scheduled to meet with the top four congressional leaders Monday in a high-stakes sit-down at the White House that could determine whether the federal government shuts down this week.Funding is set to run out at 12:01 a.m. Wednesday unless Trump and leaders on Capitol Hill can reach an eleventh-hour agreement.The Democratic leaders of the House and the Senate, Hakeem Jeffries and Chuck Schumer, both of New York, as well as their Republican counterparts, House Speaker Mike Johnson of Louisiana and Senate Majority Leader John Thune of South Dakota, are expected to attend.The standoff represents a test of wills between the parties, with Republicans determined to flex their muscle after they won full control of the government last year, while Democrats face a restive base and see a rare opportunity to advance health care policy goals, like extending key Obamacare subsidies.Six months ago, Democrats caved in to a GOP-written funding bill, but they insist that won’t happen again unless they have a say in the final legislative product.Even though Republicans control the White House and both chambers of Congress, Democrats have leverage because it takes 60 votes to pass a bill through the Senate; the GOP has 53 seats.Schumer made it clear Sunday on NBC’s “Meet the Press” that the only way to avoid a shutdown is for Republicans to get serious about negotiating with Democrats to win their votes, and he outlined demands on health care policy.“We need the meeting,” Schumer said. “It’s a first step, but only a first step. We need a serious negotiation. Now, if the president at this meeting is going to rant and just yell at Democrats and talk about all his alleged grievances and say this, that and the other thing, we won’t get anything done.”But Thune vowed that Republican leaders won’t negotiate on a short-term bill. Instead, he said, they’re willing to come to a compromise with Democrats on a longer-term government funding bill.“What the Democrats have done here is take the federal government as a hostage — and for that matter, by extension, the American people — to try and get a whole laundry list of things that they want that special interest groups on the far left are pushing them to accomplish,” Thune said on “Meet the Press.”Leader Thune says government shutdown is ‘totally up to the Democrats’: Full interview18:12Unless one party backs down or softens its demands, the U.S. government is on track for a shutdown in less than 48 hours. Senators will return to Washington on Monday evening with no clear plan, while the House is out of session.If the government shuts down, none of the millions of federal workers in the United States would be paid, and hundreds of thousands of them would be furloughed. In recent days, White House officials had tried to allow military personnel to continue receiving pay during a shutdown, according to a source familiar with the discussions, but those efforts were unsuccessful. So military personnel wouldn’t be paid during a shutdown, either.All federal workers, including military personnel, would be paid back after a shutdown ends, whether they were required to work during the closure or not.A prolonged government shutdown could put significant strain on federal workers and military members who would forgo their paychecks. But it also could be dangerous for a U.S. economy that is showing signs of fragility. While the stock market continues to hit highs, inflation has remained stubbornly high; Trump’s tariffs are hurting U.S. farmers, small businesses and consumers; and recent college graduates face a tough job market.Speaking to NBC News by phone Sunday, Trump warned that there could be a shutdown and reiterated an earlier threat that a closure could result in his administration’s mass firings of federal workers.“There is a possibility, yeah,” he said of a shutdown. “And if there is, we are going to cut a lot of the people that … we’re able to cut on a permanent basis, and we will be doing that. I’d rather not do that.”In addition to extending Obamacare funding, Democrats are demanding to roll back cuts and changes to Medicaid that were enacted in Trump’s sweeping domestic agenda law.Trump has responded by accusing Democrats of trying to permit health care for undocumented immigrants, which they flatly dismiss as a lie.“The problem we have with the shutdown is that Democrats want to do all health care for illegal immigrants … many of whom are criminal and that we are removing from our country,” Trump told NBC News. “We’re not going to do that.”Monday’s meeting is a sign that neither party wants a shutdown — or that both sides are concerned about getting blamed in the event of one. Trump abruptly canceled a meeting with Democratic leaders last week, making a shutdown seem practically inevitable. And Republicans and Democrats have been pointing fingers at each other in recent days as the deadline ticks closer. But the risk of a shutdown — which would be the first federal closure in Trump’s second term — remains extremely high. This month, the House passed a stopgap bill to avoid a shutdown that would extend government funding at current levels through Nov. 21. The House isn’t scheduled to be back in session until Oct. 7, one week after the shutdown deadline.The Senate rejected both the House-passed extension and a separate Democratic plan that would permanently extend Obamacare subsidies set to expire at the end of the year and reverse Medicaid cuts enacted in Trump’s “big, beautiful bill.”If a last-minute deal is unexpectedly reached, Johnson would need to call House members back to Washington on short notice to keep the government’s lights on. Although the House is out of session, Jeffries has asked House Democrats to return to Washington on Monday evening to show they are working to solve the impasse.Scott WongScott Wong is a senior congressional reporter for NBC News. Sahil KapurSahil Kapur is a senior national political reporter for NBC News.Yamiche AlcindorYamiche Alcindor is a White House correspondent for NBC News.Monica Alba contributed.
September 22, 2025
CNN  —  Former President Donald Trump has been charged with 34 felony counts in an indictment unsealed Tuesday. Read the indictment and statement of facts here.
November 23, 2025
Zohran Mamdani says he’s open to an ‘alternative’ to new taxes to fund his plans
September 26, 2025
Sept. 26, 2025, 11:24 AM EDTBy Rob Wile and Steve KopackAnalysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to impose on drug product imports as soon as next week.But a series of exemptions may blunt the ultimate impact. In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S. would face a 100% tariff starting Oct. 1.U.S. imports of pharmaceuticals totaled about $213 billion in 2024, a threefold increase from a decade earlier, according to data from the United Nations Comtrade Database.With Asia alone accounting for just over 20% of those imports by value, U.S. consumers could see a “meaningful commercial hit,” Louise Loo, head of Asia economics at Oxford Economics research group, said in a note to clients. Previous studies have shown that U.S. annual spending per capita on prescription drugs is about double the rest of the developed world. In July, Trump announced a plan to “get Americans the best prices in the world for prescription drugs” that involved asking major drugmakers to match low prices they offer elsewhere in the world. However, it is not clear what actions the pharma firms have taken to begin addressing that demand. The pharmaceutical industry is already warning that the new tariffs could derail further drug development while also raising prices. “Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Alex Schriver, senior vice president for PhRMA, the drug industry’s primary lobbying group, said in a statement. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”Despite those warnings, a significant share of drug products could wind up being exempted from the new import duties. The tariffs do not appear to apply to so-called generic drugs, which account for 9 out of 10 prescriptions filled in the U.S., according to the Food and Drug Administration. The White House did not immediately respond to a request to confirm the exemption for generics, but assuming they will remain tariff-free, the impact to consumers could be more limited than feared. Trump also specified that any drug companies that currently have, or have committed to building, U.S.-based drug-making facilities would be exempted from tariffs. That’s a category that includes numerous major drugmakers. “Many pharmaceutical companies have facilities in the U.S., so it may be relatively easy to superficially expand those facilities to avoid tariffs being applied,” Paul Donovan, chief global economist at UBS Global Wealth Management, wrote in a note to clients. Analysts at JPMorgan agreed: “While there remains very limited details, we note that this will likely lead to a majority of pharma products being excluded from any tariffs” because most major companies have recently increased or have started to increase their U.S. manufacturing facilities.On the White House website, the administration maintains a “running list of new U.S. investment” from private companies. At least 15 pharmaceutical or drug makers are listed with investments ranging from new manufacturing facilities, tens of billions in expanded U.S. production and increased R&D spending. Many of those announcements would appear to meet the requirements laid out by Trump to avoid the new tariff.Two major European drugmakers, Roche and Novartis, said in statements that they expected little to no impact from the newly announced duties. “We are working to ensure that all major Novartis medicines for U.S. patients are manufactured in the U.S.,” Novartis said in a statement. “The announced 100% tariff should not have an impact.” Roche pointed to ongoing factory construction in the U.S., with multiple sites being expanded and upgraded in Kentucky, Indiana, New Jersey and California.Trump has signaled since at least April that drug imports would face tariffs. In anticipation, major drugmakers have indicated they have been stockpiling supplies, analysts said. As a result, consumers are unlikely to feel immediate effects even though the tariffs are set to kick in next week. “We think there may have been significant inventory accumulation this year,” Neil Shearing, group chief economist with Capital Economics, said in a note. This summer, Trump placed a maximum 15% tariff on most pharmaceuticals coming in from the European Union, which accounts for 60% of drugs imported by the U.S. E.U. officials believe that this agreement will shield it from the 100% duties, though they said they could not be certain. “This clear all-inclusive 15% tariff ceiling for E.U. exports represents an insurance policy that no higher tariffs will emerge for European economic operators,” a European Commission spokesperson told NBC News on Friday.Ireland’s deputy prime minister, Simon Harris, who also acts as trade minister, said his country is “studying the impact of this announcement” but added that he believed the 15% cap on pharma tariffs remained in place. Ireland alone accounts for 24% of pharma imports to the U.S.Rob WileRob Wile is a Pulitzer Prize-winning journalist covering breaking business stories for NBCNews.com.Steve KopackSteve Kopack is a senior reporter at NBC News covering business and the economy.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved